International Cannabis Weekly: 276
PRE-REGISTER – THE GLOBAL CANNABIS REPORT: 3RD EDITION
Progressive drug policy regarding cannabis at the global level has been an overwhelming success in 2022. Legalisation of high-THC cannabis for non-medical purposes will soon be a reality in several countries around the world, with some nations such as Germany and Colombia recently announcing their intention to legalise.
Decriminalisation of adult-use cannabis is also progressing globally, which may be a precursor to commercial legalisation in some regions. Conversely, medicinal cannabis hasn’t progressed as quickly in 2022 as in previous years, with just a few countries declaring their interest to legalise. Indeed, some countries have taken a backward step and increased criminalisation procedures in terms of cannabis possession.
Pre-register your interest in The Global Cannabis Report: 3rd Edition and we’ll send you a FREE copy when the report is released. Additional paid-for data packages will also be available.
SPANISH MINISTRY OF HEALTH DRAFTS A LAW THAT WILL REGULATE MEDICAL CANNABIS
NEW LEGISLATION ENSURES CANNABIS BUSINESSES WILL BE ELIGIBLE FOR SBA LOANS
- Prohibition Partners Co-Founder named as 40 under 40 within the cannabis industry.
- As its neighbours become closer to legalisation, Poland’s medical cannabis and hemp industry could flourish.
- A basic legislation proposal for introducing a regulated cannabis market in Czechia will be ready by March.
- A Milan city councillor has asked the Councillor for Welfare to legalise medicinal cannabis.
- The UK’s MHRA has released new guidance for medicinal cannabis companies operating in the UK.
- Recent surveys suggest that many patients in the UK are still accessing medication through the legacy market.
- A Nottinghamshire bespoke medicines manufacturer has been acquired by cannabis company Avida Global.
- Cantourage, Cannabis House and Together Pharma partner to increase the availability of cannabis in Poland.
- Malta will now start the procedure of opening cannabis social clubs in February 2023.
- Herb reviews this year’s Business of Cannabis: New York and what you could have missed out on.
- New York’s equity-focused rollout of its cannabis market relies heavily on a US$200 million fund.
- Nevada’s Cannabis Compliance Board has held lotteries this week to select cannabis lounge licences.
- Major shifts are expected in the North American cannabis industry in the coming years, particularly for investors.
- South Dakota medical cannabis patients won’t be denied hunting licences, says expert.
- Halo Collective looks to increase its production to max capacity at its Oregon facility to meet demand.
- Cannabis businesses in Michigan are set to offer free cannabis to veterans in the state.
- The Minnesota Department of Health will add IBS and OCD to the list of qualifying medical conditions to access cannabis.
- Idaho activists have begun collecting signatures for a medical cannabis legalisation initiative.
- Greenway Greenhouse Cannabis completes its expansion to 167,000 sq. ft of growing space.
- Trees Corporation announces it has closed a financing round to fund the opening of a new Ontario store.
- Organigram reports record fourth quarter results as revenue rises 19% sequentially to C$45.5 million.
- Ghost Drops announces the acquisition of an Ontario-based, federally licensed cannabis processing facility.
- StateHouse Holdings revenue has declined by 11% sequentially to US$30.8 million.
- Statistics Canada reveals that British Columbia cannabis sales hit an all-time high in the month of September.
- The Manitoba government has introduced legislation to repeal the 6% levy placed on cannabis retailers.
- Greenlane Holdings has announced a new partnership with Wild Green Canada to streamline B2B operations.
Join 1,500 leaders from thriving cannabis companies, investors actively deploying capital into the market, plus key politicians – a crucial combination to drive your business forward and to navigate this ever-changing field.
Book your seat for 2–3 May 2023 now – join the global industry in London to set the framework for cannabis going mainstream across Europe.
LATAM & The Caribbean
- The presidents of Colombia and Mexico have announced they will work together to reshape drug policy.
- An agriculture conglomerate has received the first authorisation to grow and process hemp in Costa Rica.
- Anvisa has approved the manufacture of another medical cannabis product in Brazil.
- A new study has revealed that cannabis tourism can attract 100,000 potential customers per year in Uruguay.
- Khiron Life Sciences reports a 24% drop in revenue for Q3, primarily due to reduced sales in Colombia.
- Legalise Cannabis Victoria is cautiously optimistic it can win two upper house seats in the state election.
- Greek Australian Rob Keldoulis has bought a 44-hectare medicinal cannabis farm in Tasmania.
- Three new high-THC cannabis flower products have landed in Australia from Little Green Pharma.
- Cronos Australia is exploring overseas expansion and distribution of non-cannabis products to grow the business.
- Cannabis sales in Asia could skyrocket by more than 10 times their current size by 2026.
- A Korean pharmaceutical firm will partner with a Japanese company to develop a CBD ‘film’ for oral intake.
Africa & The Middle East
- A publicly traded company switches from cannabis to real estate as Israel’s cannabis market withers.
- Israel’s largest commercial quantity of cannabis extract is being exported to Europe by Cannbit-Tikun Olam.
- Deputy minister says the cannabis sector shows huge potential for eradicating poverty in South Africa.
on the global cannabis industry
International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 80,000+ subscribers.